The Future of Pharmaceuticals: How Cannabinoids Are Redefining the Industry
In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.
Fierce Pharma2d
Pharma majors put lobbyists to work to stagger tariff rollout: Reuters
The talks between the administration and the industry, which have been taking place behind closed doors, have given some ...
Fierce Biotech9d
Drug development cost pharma $2.2B per asset in 2024 as GLP-1s drive financial return: Deloitte
The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...
SWI swissinfo.ch1d
Pharma’s Tariff Reprieve Will Be Temporary as More Levies Loom
The drug industry won a reprieve from sweeping tariffs announced by President Donald Trump on Wednesday, though it could be ...
Ohio economy saw $2.4 billion boost from pharma clinical trials in 2023
Discover how pharmaceutical industry-funded drug trials are creating jobs and driving economic growth in the Buckeye State.
The Manila Times13d
Pharmaceutical industry delivers value proposition to Finnish Government: billions to be invested by 2030
Pharmaceutical industry delivers value proposition to Finnish Government: billions to be invested by 2030 In 2023, ...
Pharma stocks survive market rout on tariff exemption, but uncertainty continues
Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from ...